PARLIAMENTARY WRITTEN QUESTION
(29 August 2025)

To ask the Secretary of State for Environment, Food and Rural Affairs, what correspondence his Department has had with the Friedrich Loeffler Institute on the development of a vaccine for Bluetongue Virus serotype 12.

Asked by:
Sarah Bool (Conservative)

Defra has not had any correspondence with the Friedrich Loeffler Institute regarding the development of a vaccine for bluetongue virus serotype 12. However, Defra continues to work closely with key domestic and international partners, including vaccine manufacturers, to monitor the availability and development of vaccines for bluetongue virus, including serotype 12.

Answered by:
()